Sarcopenia (Myosteatosis) at Screening CT Colonoscopy in 79-Year-Old Woman With Subsequent Hip Fracture

Sarcopenia (Myosteatosis) at Screening CT Colonoscopy in 79-Year-Old Woman With Subsequent Hip Fracture: A & B. Image at L1 vertebral level without (A) and with (B) overlay of automated skeletal muscle segmentation (B, red). Intramuscular fat is present within paraspinal muscles (A, yellow circle). Mean muscle attenuation is similar for manually placed ROI (1.8 HU) and automated tool (3.9 HU), being markedly decreased for both approaches. Muscle cross-sectional area is relatively preserved when intramuscular fat is included.

C & D. CT images at L3 level without (C) and with (D) muscle segmentation demonstrate similar findings.

E. Hip radiograph demonstrates left intertrochanteric femoral fracture that occurred when patient fell 2 years later. Patient died 4 years after falling.


August 19, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), use of the L1 vertebral level — typically included on both chest and abdominal computed tomography (CT) examinations—rather than the L3 level expands the reach of opportunistic CT screening for sarcopenia.

“Automated CT-based measurements of muscle attenuation for myosteatosis at the L1 level compare favorably with previously-established L3 level measurements and clinical risk scores for predicting hip fractures and death,” wrote lead investigator Perry J. Pickhardt from the University of Wisconsin School of Medicine & Public Health in Madison. “Assessment for myopenia was less predictive of outcomes at both levels.”

Pickhardt and colleagues’ retrospective study included 9,223 patients (4,071 men, 5,152 women; mean age, 57 years) who underwent unenhanced low-dose abdominal CT. Muscle assessment for myosteatosis (mean attenuation) and myopenia (cross-sectional area) at the L1 and L3 levels was done via a previously validated fully-automated deep learning tool. Performance for predicting hip fractures and death was compared between L1 and L3 measures, then evaluated using FRAX score and Framingham risk score, respectively.

Among the 9,223 asymptomatic adults who underwent abdominal CT, muscle attenuation measurements at the L1 and L3 levels showed similar utility in predicting subsequent hip fracture and death. Meanwhile, muscle attenuation measurements at both levels showed comparable performance as established clinical risk scores.

The assessment of muscle attenuation (myosteatosis) performed better than the assessment of muscle area (myopenia) “likely due in part to the automated tool’s inclusion of intramuscular fat within the segmented areas,” the authors of this AJR article added.

For more information: www.arrs.org


Related Content

News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
News | Breast Imaging

June 2, 2025 — Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S ...

Time June 02, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop ...

Time May 29, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Imaging Software Development

May 20, 2025 – Intelerad, a provider of medical imaging software solutions, recently announced its prime partnership ...

Time May 21, 2025
arrow
Subscribe Now